Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.

Suppr

超能文献

作者信息

Tascini C, Menichetti F, Bozza S, Del Favero A, Bistoni F

出版信息

J Antimicrob Chemother. 1998 Aug;42(2):270-1. doi: 10.1093/jac/42.2.270.

DOI:10.1093/jac/42.2.270

PMID:9738852

Abstract

摘要

相似文献

Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.

J Antimicrob Chemother. 1998 Aug;42(2):270-1. doi: 10.1093/jac/42.2.270.

In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.

J Antimicrob Chemother. 2000 May;45(5):712-3. doi: 10.1093/jac/45.5.712.

In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.

J Chemother. 1996 Dec;8(6):416-9. doi: 10.1179/joc.1996.8.6.416.

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.舒巴坦单用及与氨苄西林联合用于多重耐药鲍曼不动杆菌所致医院感染的疗效

J Antimicrob Chemother. 1998 Dec;42(6):793-802. doi: 10.1093/jac/42.6.793.

In vitro effect of ampicillin/sulbactam on Acinetobacter species.

Microbios. 2001;106 Suppl 2:97-104.

In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.

Int J Antimicrob Agents. 2002 Nov;20(5):390-2. doi: 10.1016/s0924-8579(02)00207-8.

Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods.采用 E 试验和棋盘法测定多黏菌素 B 和利福平联合氨苄西林/舒巴坦或头孢哌酮/舒巴坦对多重耐药鲍曼不动杆菌的体外活性。

Jpn J Infect Dis. 2013;66(6):463-8. doi: 10.7883/yoken.66.463.

Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.耐多粘菌素、耐碳青霉烯类鲍曼不动杆菌可被三种单独无活性的药物联合使用所根除。

J Antimicrob Chemother. 2017 May 1;72(5):1415-1420. doi: 10.1093/jac/dkx002.

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.黏菌素、利福平、亚胺培南和舒巴坦/氨苄西林单独或联合使用对产OXA-58碳青霉烯酶的流行多重耐药鲍曼不动杆菌分离株的比较活性。

Int J Antimicrob Agents. 2007 Dec;30(6):537-40. doi: 10.1016/j.ijantimicag.2007.07.007. Epub 2007 Sep 11.

In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates.

J Antimicrob Chemother. 1994 Aug;34(2):298-300. doi: 10.1093/jac/34.2.298.

引用本文的文献

MTL genotypes, phenotypic switching, and susceptibility profiles of Candida parapsilosis species group compared to Lodderomyces elongisporus.近平滑念珠菌物种组与长孢洛德酵母相比的MTL基因型、表型转换及药敏谱

PLoS One. 2017 Aug 3;12(8):e0182653. doi: 10.1371/journal.pone.0182653. eCollection 2017.

New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies.血液系统恶性肿瘤患者细菌血流感染的流行病学和治疗新视角

Mediterr J Hematol Infect Dis. 2015 Jul 1;7(1):e2015044. doi: 10.4084/MJHID.2015.044. eCollection 2015.

Efficacy and safety of polymyxins for the treatment of Acinectobacter baumannii infection: a systematic review and meta-analysis.多黏菌素治疗鲍曼不动杆菌感染的疗效与安全性：一项系统评价和荟萃分析

PLoS One. 2014 Jun 9;9(6):e98091. doi: 10.1371/journal.pone.0098091. eCollection 2014.

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients.实体器官移植受者中广泛耐药鲍曼不动杆菌感染的流行病学、临床特征和结局。

PLoS One. 2012;7(12):e52349. doi: 10.1371/journal.pone.0052349. Epub 2012 Dec 20.

Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.多粘菌素与多粘菌素联合利福平治疗碳青霉烯类耐药鲍曼不动杆菌呼吸机相关性肺炎。

Epidemiol Infect. 2013 Jun;141(6):1214-22. doi: 10.1017/S095026881200194X. Epub 2012 Sep 7.

In vitro activity of antibiotic combinations against multidrug-resistant strains of Acinetobacter baumannii and the effects of their antibiotic resistance determinants.抗生素联合用药对多重耐药鲍曼不动杆菌的体外活性及其耐药决定因素的影响。

FEMS Microbiol Lett. 2012 Mar;328(1):26-31. doi: 10.1111/j.1574-6968.2011.02480.x. Epub 2012 Jan 6.

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore.在新加坡，多黏菌素 B、利福平、替加环素单独及联合用药对碳青霉烯类耐药鲍曼不动杆菌的体外活性。

PLoS One. 2011 Apr 21;6(4):e18485. doi: 10.1371/journal.pone.0018485.

Management of meningitis due to antibiotic-resistant Acinetobacter species.耐抗生素不动杆菌属所致脑膜炎的管理

Lancet Infect Dis. 2009 Apr;9(4):245-55. doi: 10.1016/S1473-3099(09)70055-6.

Acinetobacter baumannii: emergence of a successful pathogen.鲍曼不动杆菌：一种成功病原体的出现

Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.

Polymyxins revisited.多粘菌素再探讨。

Clin Microbiol Rev. 2008 Jul;21(3):449-65. doi: 10.1128/CMR.00006-08.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验